Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

GHRH (1-29) vs Sermorelin — Peptide Comparison

GHRH (1-29) vs Sermorelin — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

At a Glance

Quickcomparison

Dose Range

GHRH (1-29)

100–300 mcg

Sermorelin

Frequency

Once daily

Administration

Subcutaneous injection

Cycle Length

8-12 weeks

12+ weeks

Onset Speed

Moderate (1-2 weeks)

Evidence Level

Strong human trials (Phase 3 or FDA approved)

Moderate human trials (Phase 1-2)

Efficacy

Benefitratings

Growth and Development

Body Composition

Performance and Recovery

GH Optimization

Sleep Quality

Technical Data

Compoundspecifications

Molecular Formula

C149H246N44O42S

Molecular Weight

3357.9 g/mol

Half-Life

~10-20 minutes

Bioavailability

Subcutaneous: moderate; Intranasal: 3-5%

CAS Number

86168-78-7

10-20 minutes

High when injected subcutaneously; degraded orally

Protocols

Dosingtiers

starting

30 mcg/kg (about 2-2.5 mg for a 70-80 kg adult)

Once daily at bedtime

Ongoing

Weight-based dose from the FDA-approved GRF 1-29 product (Geref) used for growth hormone deficiency, given at night to match natural GH release [5].

standard

200-300 mcg

Once daily at bedtime, often 5 nights per week

3-6 month cycles

Fixed-dose protocol commonly used in adult practice for GH support; lower than the weight-based pediatric dose and dosed at night before sleep [5].

100-200 mcg

4-6 weeks

Lower nightly dose used in practice; GHRH(1-29) nightly injections raised GH/IGF-1 in older adults [2][3].

3-6 months

Common adult maintenance dose; twice-daily GHRH(1-29) reversed age-related GH/IGF-1 decline in men [1][2].

Applications

Bestsuited for

Helping Kids Catch Up in Height

Children diagnosed with growth hormone deficiency struggle to reach normal heights. GHRH (1-29) works by sending a signal to the pituitary gland that says 'make more growth hormone.' Studies show children getting daily 30 mcg/kg doses at bedtime experienced sustained improvements in height velocity over 12+ months. It's gentle and lets the body do the work naturally.

Testing for Growth Problems

Doctors need a safe, accurate way to figure out if someone has a growth hormone deficiency. Giving a small dose of GHRH (1-29) and measuring the growth hormone response is fast and specific. It's like asking your pituitary gland 'can you produce growth hormone?' and listening to the answer.

Natural Optimization for Adults

Some adults have lower-than-optimal growth hormone levels as they age. GHRH (1-29) stimulates the body's own hormone factories rather than replacing hormones artificially. This approach keeps your body's natural feedback loops working properly.

Adults Experiencing Age-Related GH Decline

After age 30, your growth hormone production naturally declines about 14% per decade. Sermorelin helps restore more youthful GH levels by stimulating your own pituitary rather than shutting it down with external hormones. It's like giving your hormone system a gentle nudge back to where it used to be.

Body Composition Optimizers

If you're struggling to lose stubborn belly fat or build lean muscle despite diet and exercise, sermorelin can help shift your body composition over time. Studies show it increases lean mass and reduces fat, especially in older adults whose natural GH has declined.

Sleep Quality Seekers

Growth hormone is intimately tied to deep, restorative sleep. By enhancing your natural nighttime GH pulses, sermorelin often improves sleep quality as a welcome side effect. Many users report falling asleep faster and waking more refreshed.

Those Wanting a Safer Alternative to HGH

Direct HGH injections bypass your body's feedback system and can suppress your own production. Sermorelin works differently—it asks your pituitary to make more GH naturally. This preserves your body's regulatory mechanisms and carries a lower risk of side effects.

Safety Profile

Sideeffects

Common

Facial flushing

Injection site discomfort

Mild dizziness

Uncommon

Nausea

Headache

Local allergic reaction

Serious

Cardiovascular complications

Injection site reactions

Sleepiness or drowsiness

Hyperactivity or difficulty sleeping

Severe allergic reaction

Research Status

Safety& evidence

FDA Status

FDA approved for this use

Safety Overview

GHRH (1-29) has been studied extensively in both children and adults. It works by mimicking a natural hormone your body already produces, making it relatively gentle. Side effects are typically mild and temporary, mainly limited to facial flushing and minor injection site reactions. Long-term studies show it's well-tolerated when used as directed.

Contraindications

xActive malignancy or recent cancer diagnosis

xAcute critical illness or severe infection

xKnown hypersensitivity to sermorelin or any component

FDA approved for other use

Sermorelin has an excellent safety profile backed by FDA approval history and decades of clinical use. Unlike direct HGH, it works through your body's natural feedback mechanisms, which inherently limits excessive hormone levels. Side effects are generally mild and transient—mostly injection site reactions and occasional flushing. The peptide was FDA-approved in 1997 for pediatric use and is one of the most well-studied growth hormone secretagogues available.

xActive cancer or history of cancer

xPregnancy or breastfeeding

xKnown allergy to sermorelin or any peptide components

xPituitary tumors or other pituitary disorders

xDiabetic retinopathy

Decision Guide

Which isright for you?

Choose GHRH (1-29) if...

Children with growth hormone deficiency who need to catch up in height

Adults seeking to optimize natural growth hormone levels

People being tested for growth hormone deficiency

Choose Sermorelin if...

Anti-aging and vitality

Body composition improvement

Sleep quality enhancement

Exercise recovery

Connected topics

Follow this recovery question